Astera Labs (NASDAQ:ALAB) Stock Price Down 2.2% - Time to Sell?

Key Points

• Astera Labs' stock price decreased by 2.2% to $156.31, amid increased trading volume of 5,742,158 shares, reflecting a 10% rise from the average session volume.
• Analysts have mixed opinions on Astera Labs, with Zacks Research downgrading the stock to a "hold" and others like Morgan Stanley and Deutsche Bank setting target prices of $200.00.
• Insider activity shows significant selling, with Director Manuel Alba selling 183,000 shares at an average price of $173.27, representing a 32.17% decrease in his position.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s stock price fell 2.2% during trading on Monday . The company traded as low as $153.40 and last traded at $156.31. 5,742,158 shares changed hands during trading, an increase of 10% from the average session volume of 5,239,797 shares. The stock had previously closed at $159.80.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Zacks Research downgraded shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 6th. Morgan Stanley lifted their target price on shares of Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a report on Friday, August 29th. TD Cowen assumed coverage on shares of Astera Labs in a report on Wednesday, October 1st. They set a "hold" rating and a $200.00 target price for the company. Weiss Ratings reiterated a "hold (c-)" rating on shares of Astera Labs in a research note on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a research note on Tuesday, September 2nd. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $162.06.

Astera Labs Trading Down 2.2%

The company has a market capitalization of $25.98 billion, a price-to-earnings ratio of 279.13, a PEG ratio of 3.98 and a beta of 1.43. The firm's 50-day moving average price is $199.68 and its 200 day moving average price is $128.80.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. The company had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm's revenue was up 149.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the sale, the director directly owned 385,863 shares of the company's stock, valued at $66,858,482.01. The trade was a 32.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Michael Truett Tate sold 18,861 shares of the business's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $3,461,182.11. Following the sale, the chief financial officer directly owned 259,512 shares in the company, valued at $47,623,047.12. The trade was a 6.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,092,997 shares of company stock worth $192,231,120 in the last ninety days. Insiders own 12.50% of the company's stock.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors have recently added to or reduced their stakes in the business. Nicholas Wealth LLC. bought a new stake in Astera Labs during the 3rd quarter worth approximately $227,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Astera Labs in the 3rd quarter valued at $86,152,000. Merit Financial Group LLC boosted its stake in shares of Astera Labs by 3.1% in the 3rd quarter. Merit Financial Group LLC now owns 5,683 shares of the company's stock valued at $1,113,000 after purchasing an additional 170 shares during the last quarter. Calamos Advisors LLC bought a new stake in shares of Astera Labs in the 3rd quarter valued at $1,808,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al boosted its stake in shares of Astera Labs by 75.5% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 17,900 shares of the company's stock valued at $3,505,000 after purchasing an additional 7,700 shares during the last quarter. 60.47% of the stock is owned by institutional investors.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.